Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Diabetes drug semaglutide may influence cortisol levels, small study suggests

NCT ID NCT06608433

First seen Feb 12, 2026 · Last updated Jun 21, 2026 · Updated 21 times

Summary

This completed study looked at how a single dose of semaglutide (Rybelsus), a drug used for diabetes and weight loss, affects cortisol and other stress hormones in healthy men. Twenty-two volunteers received either semaglutide or a placebo pill, and researchers measured changes in their cortisol levels. The goal was purely to learn more about the body's stress response, not to treat any disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADRENAL INSUFFICIENCY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University Hospital Basel

    Basel, Switzerland

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

semaglutide (Rybelsus)

What this could lead to

If it works, this could help doctors understand how GLP-1 drugs like semaglutide affect stress hormones and adrenal function.

What could go wrong

This is a very small, early study in healthy volunteers, not patients. It only tests a single dose and is not designed to treat or diagnose any condition.

Conditions

The condition(s) this trial relates to.

adrenocortical insufficiency heritable pulmonary arterial hypertension mild hyperphenylalaninemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.